Walking May Help Protect Kidney Disease Patients Against Heart Disease, Infections
Just a modest amount of exercise may help reduce kidney disease patients' risks of developing heart disease and infections, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Heart disease and infection are major complications and the leading causes of death in patients with chronic kidney disease. It is now well established that immune system dysfunction is involved in both of these pathological processes. Specifically, impaired immune function predisposes to infection, while persistent immune activation leads to a state of chronic inflammation that can damage the insides of blood vessels and increase heart disease risk. Physical exercise may confer benefits by exerting anti-inflammatory effects and enhancing immunity, but such effects have been largely unexplored in kidney disease.
João Viana, PhD, Nicolette Bishop, PhD (Loughborough University, in the UK), and Alice Smith, PhD (University of Leicester) and their colleagues designed a study to explore the impact of exercise on a range of immune and inflammatory parameters in patients with chronic kidney disease.
In an acute exercise study conducted in 15 patients, 30 minutes of walking improved the responsiveness of immune cells called neutrophils to a bacterial challenge in the post-exercise period. It also induced a systemic anti-inflammatory environment in the body.
In a regular exercise study, six months of regular walking (30 minutes/day, five times/week) reduced immune cell activation and markers of systemic inflammation in 20 patients compared with another 20 patients who did not increase their usual activity levels over the same period of time.
"Thus, exercise exerts anti-inflammatory effects in patients with kidney disease and may in this way reduce their high risk for heart disease," said Dr. Viana. "Our study also found no evidence that this level of exercise might be harmful to the immune system in people with kidney disease."
Study co-authors include George Kosmadakis, Dipl Med, Emma Watson, PhD, Alan Bevington, DPhil, and John Feehally, DM.
Source: American Society of Nephrology
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
